United States · FDA National Drug Code directory
Levetiracetam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80425-0565_45a04d05-6f76-0d6b-e063-6294a90a935d
- Product NDC
- 80425-0565
- Form
- TABLET
- Composition / generic term
- Levetiracetam
- Labeler
- Advanced Rx of Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251210
- Source listing expiry
- 20261231
Source-listed ingredients
- LEVETIRACETAM — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET in 1 BOTTLE (80425-0565-1) · 80425-0565-1
- 30 TABLET in 1 BOTTLE (80425-0565-2) · 80425-0565-2
- 60 TABLET in 1 BOTTLE (80425-0565-3) · 80425-0565-3
- 90 TABLET in 1 BOTTLE (80425-0565-4) · 80425-0565-4
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →